(Date:9/4/2008)...y of the September 11 attacks approaches, the Amer...st describing an array of technologies to help ass...dcast is the sixth episode in ACS,s acclaimed Glo...th new episodes posted twice monthly, Global Chall... the 21st Century, and explains how chemists and o...
(Date:9/4/2008)...hers at the HudsonAlpha Institute and Stanford Uni... other organizations, today publishes a comprehens...cer glioblastoma. These results are the first from...a collaborative effort funded by the National Canc...h Institute of the National Institutes of Health. ...
(Date:9/4/2008)...y have joined forces to develop a world-first,com... premature birth with greater accuracy., The Univ...nd Symbion Pathology are combining,expertise in m...lop a computer program to predict,women at risk o...s occur in Australia each year. Premature birth is...
(Date:9/4/2008)...eap in medicine. In the future, new tissue grown i...ew cells take the place of damaged cells in the br...ources, which opens difficult ethical and complica...g to adult human stem cells, culled from a person,...ted from various tissues in the body ― from ...
Breaking Biology News(10 mins):New 'chemical radar' among national security innovations in ACS podcast 2New 'chemical radar' among national security innovations in ACS podcast 3Collaboration between researchers yields more comprehensive portrait of brain cancer 2World-first to predict premature births 2Tel Aviv University researchers create new stem cell screening tool 2Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms 30 1Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms 30 2Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms 30 3CEL SCI Secures Manufacturing Facility for Multikine Cancer Drug 28 1CEL SCI Secures Manufacturing Facility for Multikine Cancer Drug 28 2CEL SCI Secures Manufacturing Facility for Multikine Cancer Drug 28 3CEL SCI Secures Manufacturing Facility for Multikine Cancer Drug 28 4Spherix Reports Second Quarter Earnings 26 1Spherix Reports Second Quarter Earnings 26 2Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine 28R 29 28VNP40101M 29 in Elderly AML 24 1Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine 28R 29 28VNP40101M 29 in Elderly AML 24 2Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine 28R 29 28VNP40101M 29 in Elderly AML 24 3Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine 28R 29 28VNP40101M 29 in Elderly AML 24 4...mary strategies for regulating its genome is a kin... molecules called microRNAs, or miRNAs. First obse...to inactivate messenger RNA, itself responsible fo... been eager to know more about miRNAs, clearly imp... gone unnoticed for so long. How are they produced...
...lts from a study in Botswana, Harvard School of Pu...h HIV-1 subtype C in resource-poor settings, who r...omparable results to those in the developed world.... infrastructure help ensure this success, accordin...Journal of Acquired Immune Deficiency Syndromes (J...
...thogens, the Chlamydiae know us very, very well. T...ls half a billion years ago by reprogramming cellu...dial infections are responsible for a range of ail...ical pneumonias to chronic severe disorders such a... The Centers for Disease Control says that Chlamyd...
... reported this week in Current Biology, tsunami da...e 2004 Sumatra-Andaman earthquake was occasionally...ly when compared to damage from chronic human misu...tsunami of December 26, 2004, a team of ecologists...tion Society-Indonesia Program, and Syiah Kuala Un...
Other Biology News:Twin molecular scissors link creation of microRNAs with gene-silencing 2Largest computational biology simulation mimics life’s most essential nanomachine 2Chlamydia parasite lives off our fat 2(Date:9/5/2008)...-FirstCall/ -- BioSpecifics,Technologies Corp. (OT...ny,developing first in class collagenase based pro...ment to significantly improve the deal terms relat...s disease by buying down its,future royalty obliga... has modified its previously announced agreement t...
(Date:9/5/2008)... -- Campbell Alliance, the leading,management cons... biotech,industry, today announced that leaders fr...gagements at the Center for Business Intelligence,...ales Model, to be held September,8 and 9, 2008, at...ard-winning sales professional before becoming a p...
(Date:9/4/2008)...wire-FirstCall/ -- MedQuist Inc.,(Nasdaq: MEDQ ) ...ected John,F. Jastrem, Colin J. O,Brien, and Andre...2008. Prior to the election of the new directors, ...ard from seven to 10 members., According to MedQu...,pleased to have this opportunity to further enhan...
(Date:9/4/2008)...ire-FirstCall/ -- BioForm Medical,Inc. (Nasdaq: ...he fourth,quarter and full fiscal year ended June ...rter ended June 30, 2008 as compared to $15.4 mill...se of $1.3 million or 8.4%.,The net loss was $20.0...mpared to a net loss of $4.9 million for the quart...
Breaking Biology Technology:BioSpecifics Technologies Corp. Buys Down Royalties for Peyronie's Disease 2Campbell Alliance Sales Practice to Present at CBI's Leadership Summit on Evolving the Pharma Sales Model 2Campbell Alliance Sales Practice to Present at CBI's Leadership Summit on Evolving the Pharma Sales Model 3Campbell Alliance Sales Practice to Present at CBI's Leadership Summit on Evolving the Pharma Sales Model 4MedQuist Announces Additions to Board of Directors 2MedQuist Announces Additions to Board of Directors 3BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 2BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 3BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 4BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 5BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 6BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 7BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 8BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 9...se profiling, quantitative measurement of kinase k...lt on the flexible and powerful Paraflo microfluid...re available as part of our comprehensive Protein ...ustom Probe Content Probe content is completely c...
...Package Superior Protein Detection and Quantitati...teomic Imaging System is a highly sensitive in ima...ience research applications. ProXPRESS 2D provides... dyes in the UV and VIS spectrum range with its CC...
... characterize high-value, low-abundant proteins fa...he Agilent Multiple Affinity Removal System allows...oteins from human serum, plasma, CSF samples and m... system, you can: Remove six targeted, high-abun...
...r laboratory research use only. The individual ti...embedded in paraffin. Tissue identification and d... Tissue cores were removed from their paraffin blo...ock, in an array pattern, using Chemicons Advanced...
Biology Products: